Rare Case of Leydig Cell Tumor with Type I Diabetes Mellitus Causing Female Pattern Hair Loss

    August 2019 in “ Journal of Dermatology
    Miki Fukuda, Noriko Arase, Michio Otsuki, Kentaro Kuritani, Sachiko Hijiki, Satoshi Nojima, Ichiro Katayama, Mika Terao, Shigeki Inui, Manabu Fujimoto
    Image of study
    TLDR Woman with diabetes had hair loss due to rare ovarian tumor; surgery improved hair growth.
    A 54-year-old woman with type 1 diabetes mellitus (T1DM) and chronic kidney disease visited a dermatology department for frontal hair loss. She was diagnosed with female pattern hair loss (FPHL) and had a few recurrent acnes on her chin. Her serum testosterone levels were high, and pelvic MRI showed the presence of a left ovarian tumor that was 23 mm in diameter. The patient underwent laparoscopic bilateral salpingo-oophorectomy, and the tumor was identified as a Leydig cell tumor (LCT). Three months after the operation, her alopecia significantly improved, and serum testosterone levels were restored to normal levels. The findings of the case suggest that FPHL with LCT is associated with obesity, lifestyle diseases, T2DM, and T1DM.
    Discuss this study in the Community →

    Research cited in this study

    2 / 2 results

    Related Community Posts Join

    6 / 1000+ results

    Similar Research

    5 / 1000+ results
      An Approach to the Patient with Hirsutism

      research An Approach to the Patient with Hirsutism

      49 citations, September 2012 in “˜The œJournal of clinical endocrinology and metabolism/Journal of clinical endocrinology & metabolism”
      The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.
      Evidence-Based Approach to Cutaneous Hyperandrogenism in Women

      research Evidence-Based Approach to Cutaneous Hyperandrogenism in Women

      42 citations, July 2015 in “Journal of The American Academy of Dermatology”
      The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.